1. Home
  2. CRGO vs PLRX Comparison

CRGO vs PLRX Comparison

Compare CRGO & PLRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Freightos Limited Ordinary shares

CRGO

Freightos Limited Ordinary shares

HOLD

Current Price

$1.23

Market Cap

66.7M

Sector

Finance

ML Signal

HOLD

Logo Pliant Therapeutics Inc.

PLRX

Pliant Therapeutics Inc.

HOLD

Current Price

$1.09

Market Cap

68.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRGO
PLRX
Founded
2012
2015
Country
Spain
United States
Employees
382
N/A
Industry
Blank Checks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
66.7M
68.7M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
CRGO
PLRX
Price
$1.23
$1.09
Analyst Decision
Strong Buy
Hold
Analyst Count
1
4
Target Price
$2.40
$2.67
AVG Volume (30 Days)
55.8K
706.8K
Earning Date
05-26-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
29.97
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$10.61
N/A
Revenue Next Year
$16.85
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.17
$1.05
52 Week High
$4.24
$1.95

Technical Indicators

Market Signals
Indicator
CRGO
PLRX
Relative Strength Index (RSI) 42.22 40.45
Support Level $1.17 N/A
Resistance Level $1.45 $1.37
Average True Range (ATR) 0.10 0.05
MACD 0.02 -0.00
Stochastic Oscillator 26.11 19.23

Price Performance

Historical Comparison
CRGO
PLRX

About CRGO Freightos Limited Ordinary shares

Freightos Ltd operates as a vendor-neutral booking and payment platform for international freight. Its platform supports supply chain efficiency and agility by enabling real-time procurement of ocean and air shipping across more than ten thousand importers/exporters, thousands of forwarders, and dozens of airlines and ocean carriers. The company operates in two segments: the Platform segment and the Solutions segment. The majority of the revenue is derived from the Solutions segment, which provides software tools and data to help industry participants automate their pricing, sales, and procurement processes. Geographically, it generates the maximum revenue from Europe, and the rest from the United States, Hong Kong and Others.

About PLRX Pliant Therapeutics Inc.

Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of integrin-based therapies. The company operates as a single reportable segment focused on developing and commercializing novel integrin-based treatments. Its lead product candidate, PLN-101095, is an oral small molecule targeting integrins for the treatment of solid tumors. The company also advances a pipeline of integrin-based programs across multiple disease areas through its proprietary drug discovery platform.

Share on Social Networks: